Search research articles
Contact Us
Filters
Showing results (11-20 of 84) with videos related to
Page
of 9
Sort By:
JAMA Otolaryngology-- Head & Neck Surgery
|
June 19, 2015
Challenges in Histologic Diagnosis of Nonchordomatous Lesions of the Clivus
Julia Kristin, Jörg H Schipper, Muhammad Jalkhi, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
October 22, 2022
Lack of Harmonized Adherence Criteria in Allergen Immunotherapy Prevents Comparison of Dosing and Application Strategies: A Scoping Review
Caroline Beutner, Jochen Schmitt, Margitta Worm, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
December 5, 2014
Taking a fresh look at the skull base in otorhinolaryngology with web-based simulation: Student's Interactive Skull-Base Trainer (SISTer)
Peter Freiherr von Sass, Kathrin Scheckenbach, Martin Wagenmann, et al.
Clinical and Translational Allergy
|
March 28, 2022
Allergen immunotherapy during the COVID-19 pandemic-A survey of the German Society for Allergy and Clinical Immunology
Oliver Pfaar, Eckard Hamelmann, Ludger Klimek, et al.
Clinical and Translational Allergy
|
August 3, 2012
The release of IL-31 and IL-13 after nasal allergen challenge and their relation to nasal symptoms
Ralf Baumann, Matthaeus Rabaszowski, Igor Stenin, et al.
Allergologie Select
|
January 11, 2021
Severe allergic reactions to the COVID-19 vaccine - statement and practical consequences
Jörg Kleine-Tebbe, Ludger Klimek, Eckard Hamelmann, et al.
Journal of Negative Results in Biomedicine
|
December 28, 2010
The checkpointkinase 2 (CHK2) 1100delC germ line mutation is not associated with the development of squamous cell carcinoma of the head and neck (SCCHN)
Kathrin Scheckenbach, Galatia Papadopoulou, Thomas K Hoffmann, et al.
American Journal of Rhinology & Allergy
|
July 26, 2013
Comparison of the nasal release of IL-4, IL-10, IL-17, CCL13/MCP-4, and CCL26/eotaxin-3 in allergic rhinitis during season and after allergen challenge
Ralf Baumann, Matthaeus Rabaszowski, Igor Stenin, et al.
Auris, Nasus, Larynx
|
October 28, 2009
Emerging therapeutic options in fulminant invasive rhinocerebral mucormycosis
Kathrin Scheckenbach, Oliver Cornely, Thomas K Hoffmann, et al.
International Archives of Allergy and Immunology
|
April 16, 2018
Activin-A Is a Pro-Inflammatory Regulator in Type-2-Driven Upper Airway Disease
Adam M Chaker, Ulrich Matthias Zissler, Nikolaos Poulos, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 84) with videos related to
Sort By:
Page
of 9
JAMA Otolaryngology-- Head & Neck Surgery
|
June 19, 2015
Challenges in Histologic Diagnosis of Nonchordomatous Lesions of the Clivus
Julia Kristin, Jörg H Schipper, Muhammad Jalkhi, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
October 22, 2022
Lack of Harmonized Adherence Criteria in Allergen Immunotherapy Prevents Comparison of Dosing and Application Strategies: A Scoping Review
Caroline Beutner, Jochen Schmitt, Margitta Worm, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
December 5, 2014
Taking a fresh look at the skull base in otorhinolaryngology with web-based simulation: Student's Interactive Skull-Base Trainer (SISTer)
Peter Freiherr von Sass, Kathrin Scheckenbach, Martin Wagenmann, et al.
Clinical and Translational Allergy
|
March 28, 2022
Allergen immunotherapy during the COVID-19 pandemic-A survey of the German Society for Allergy and Clinical Immunology
Oliver Pfaar, Eckard Hamelmann, Ludger Klimek, et al.
Clinical and Translational Allergy
|
August 3, 2012
The release of IL-31 and IL-13 after nasal allergen challenge and their relation to nasal symptoms
Ralf Baumann, Matthaeus Rabaszowski, Igor Stenin, et al.
Allergologie Select
|
January 11, 2021
Severe allergic reactions to the COVID-19 vaccine - statement and practical consequences
Jörg Kleine-Tebbe, Ludger Klimek, Eckard Hamelmann, et al.
Journal of Negative Results in Biomedicine
|
December 28, 2010
The checkpointkinase 2 (CHK2) 1100delC germ line mutation is not associated with the development of squamous cell carcinoma of the head and neck (SCCHN)
Kathrin Scheckenbach, Galatia Papadopoulou, Thomas K Hoffmann, et al.
American Journal of Rhinology & Allergy
|
July 26, 2013
Comparison of the nasal release of IL-4, IL-10, IL-17, CCL13/MCP-4, and CCL26/eotaxin-3 in allergic rhinitis during season and after allergen challenge
Ralf Baumann, Matthaeus Rabaszowski, Igor Stenin, et al.
Auris, Nasus, Larynx
|
October 28, 2009
Emerging therapeutic options in fulminant invasive rhinocerebral mucormycosis
Kathrin Scheckenbach, Oliver Cornely, Thomas K Hoffmann, et al.
International Archives of Allergy and Immunology
|
April 16, 2018
Activin-A Is a Pro-Inflammatory Regulator in Type-2-Driven Upper Airway Disease
Adam M Chaker, Ulrich Matthias Zissler, Nikolaos Poulos, et al.
Page
of 9